Originalarbeiten
Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, et al. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999; 19: 8866-75.
Herms JW, Tings T, Dunker S, Kretzschmar HA. Prion protein affects Ca2+-activated K+ currents in cerebellar purkinje cells. Neurobiol Dis 2001; 8: 324-30.
Baudewig J, Siebner HR, Bestmann S, Tergau F, Tings T, Paulus W, et al. Functional MRI of cortical activations induced by transcranial magnetic stimulation (TMS). Neuroreport 2001; 12: 3543-8.
Pantalone D, Muscas GC, Tings T, Paolucci R, Nincheri-Kunz M, Borri A, et al. Peripheral paraneoplastic neuropathy, an uncommon clinical onset of sigmoid cancer. Case report and review of the literature. Tumori 2002; 88: 347-9.
Tings T, Baier PC, Paulus W, Trenkwalder C. Restless Legs Syndrome induced by impairment of sensory spinal pathways. J Neurol 2003; 250: 499-500.
Happe S, Tings T, Helmschmied K, Neubert K, Wuttke W, Paulus W, et al. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease. Mov Disord 2004; 19: 1511-5.
Mossner R, Tings T, Beckmann I, Neumann C, Paulus W, Reich K. A close look at autoimmune muscle disorders: association of Lambert-Eaton myasthenic syndrome with dermatomyositis. Scand J Rheumatol 2004; 33: 271-5.
Tings T, Schettler V, Canelo M, Paulus W, Trenkwalder C. Impact of regular LDL apheresis on the development of restless legs syndrome. Mov Disord 2004; 19: 1072-5.
Tings T, Lang N, Tergau F, Paulus W, Sommer M. Orientation-specific fast rTMS maximizes corticospinal inhibition and facilitation. Exp Brain Res 2005; 164: 323-33.
Tings T, Stiens G, Paulus W, Trenkwalder C, Happe S. Treatment of restless legs syndrome with subcutaneous apomorphine in a patient with short bowel syndrome. J Neurol 2005; 252: 361-3.
von Spiczak S, Whone AL, Hammers A, Asselin MC, Turkheimer F, Tings T, et al. The role of opioids in restless legs syndrome: an [11C] PET study. Brain 2005; 128: 906-17.
Henning S, Tings T, Schmidt H, Tergau F, Wolf S, Scholz K, et al. A case of cerebral Whipple's disease initially presenting with isolated focal myoclonus. Eur J Neurol 2006; 13: 659-61.
Sommer M, Alfaro A, Rummel M, Speck S, Lang N, Tings T, et al. Half sine, monophasic and biphasic transcranial magnetic stimulation of the human motor cortex. Clin Neurophysiol 2006; 117: 838-44.
Happe S, Tings T, Koch W, Welsch J, Helmschmied K, Baier PC, et al. Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson's disease. J Neural Transm 2007; 114: 589-94.
Sommer M, Bachmann CG, Liebetanz KM, Schindehütte J, Tings T, Paulus W. Pregabalin in restless legs syndrome with and without neuropathic pain. Acta Neurol Scand 2007; 115: 347-50.
Übersichtsarbeiten
Kretzschmar HA, Tings T, Madlung A, Giese A, Herms J. Function of PrP(C) as a copper-binding protein at the synapse. Arch Virol Suppl 2000: 239-49.
Tings T, Trenkwalder C. Wann L-Dopa-Präparate, Dopaminagonisten oder Opioide? Therapie des Restless-legs-Syndroms. MMW Fortschr Med 2003; 145: 48-9.
Tings T, Trenkwalder C. Medikamentöse Therapie des Restless-legs-Syndroms. Pro und Kontra der medikamentösen Therapieoptionen. INFO Neurologie & Psychiatrie 2003; 5: 57-60
Tings T, Happe S. Zeitgemäße Therapie der schmerzhaften diabetischen Polyneuropathie. DiabetesNews 2004; 2: 14
Tings T, Nitsche MA, Paulus W. Kritische Stellungnahme zur Datenlage und zum Indikationsspektrum von intravenöser Valproinsäure. Z Epileptol 2007; 20: 120-4